Real-time US stock market capitalization analysis and size classification for appropriate risk assessment. We help you understand how company size impacts volatility and expected returns in different market conditions.
As of 2026-04-08, Keros Therapeutics Inc. (KROS) is trading at a current price of $12.5, marking a 2.12% gain on the day. This analysis examines key technical levels, recent market context, and potential future scenarios for the biotech stock, with no recent earnings data available for the company as of this publication. KROS has seen relatively range-bound trading in recent weeks, with price action largely tied to broader biotech sector flows rather than company-specific news. Key takeaways for
Is Keros Therapeutics (KROS) Stock heavily shorted | Price at $12.50, Up 2.12% - Price Action
KROS - Stock Analysis
3336 Comments
1560 Likes
1
Negus
Expert Member
2 hours ago
The commentary on risk versus reward is especially helpful.
π 270
Reply
2
Eaen
Power User
5 hours ago
The market is holding support levels well, a sign of underlying strength.
π 201
Reply
3
Jaidn
New Visitor
1 day ago
Such focus and energy. πͺ
π 13
Reply
4
Kaleel
Power User
1 day ago
Who else is trying to keep up with this trend?
π 27
Reply
5
Dreamie
Experienced Member
2 days ago
Truly a master at work.
π 279
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.